Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease
Published: June 16, 2014
![Mature nurse giving to senior woman Medication Instructions.](/-/media/PHD-Images/Science-News/a/a_doctor_showing_an_older_patient_instructions_for_medicines.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- Under-treatment and under-testing in women lead to increased complications and to higher rate of case fatalities.
- Atherosclerotic coronary artery disease (CAD) continues to be underrecognized and underdiagnosed in women, contributing to the high mortality.
- This statement provides modern evidence to assist in identifying the appropriate female candidates for diagnostic testing.